Zinc Mood Randomized Trial: What the Evidence Says

Quick Answer

Zinc Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• L-carnosine (β-alanyl-L-histidine) is a naturally occurring bioactive dipeptide composed of β-alanine and L-histidine, predominantly found in tissues with high metabolic demands such as skeletal muscle and the central nervous system. [Hsiao Yung-Fang (2026); evidence level 1]
• Age-associated declines in muscle carnosine content have been associated with reduced exercise capacity and increased fatigue, whereas reductions in brain carnosine levels have been linked to oxidative damage, protein aggregation, and cognitive impairment in neurodegenerative conditions or aging. [Hsiao Yung-Fang (2026); evidence level 1]
• A comprehensive review of psychiatric presentations reported that psychiatric symptoms span attention problems, anxiety, mood/behavioral disorders, and psychosis and identified > 100 IEMs associated with psychiatric manifestations; in a curated analysis, 94 IEMs were linked to psychiatric symptoms, with mood changes ranging from depressive syndromes to bipolar-like presentations. [Hachmeriyan Antoniya (2026); evidence level 3]
• Clinically, mood disorders associated with IEMs often exhibit characteristic diagnostic patterns that may aid early recognition. [Hachmeriyan Antoniya (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For zinc mood randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Hsiao Yung-Fang (2026). The Effects of Carnosine on Cognitive Function and Mental Health—A Systematic Review and Meta-Analysis. DOI: 10.3390/nu18091385. PMCID: PMC13165363. PMID: 42123986. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165363/
• Hachmeriyan Antoniya (2026). From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression. DOI: 10.3390/nu18091318. PMCID: PMC13165168. PMID: 42123920. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165168/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.